News
The FDA has approved its requested updated versions of expanded warning labels for COVID-19 vaccines. As Healio previously ...
8h
WGAU Radio on MSNFDA expands warning on rare heart risk linked to Pfizer and Moderna COVID vaccinesThe updated guidance highlights myocarditis and pericarditis, two types of heart inflammation, as possible adverse events ...
The Swedish-British pharma major AstraZeneca in partnership with the University of Oxford on Monday reported robust efficacy of up to 90% for the jointly ...
The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.
7h
Stocktwits on MSNCDC Vaccine Panel Overhauled by RFK Jr. Votes To Drop Mercury Preservative, Critics Sound AlarmA revamped U.S. vaccine advisory panel, appointed by Health Secretary Robert F. Kennedy Jr., voted 5-1 on Thursday to ...
Here’s a look at the life of Israeli Prime Minister Benjamin Netanyahu. Personal Birth date: October 21, 1949 Birth place: Tel Aviv, Israel Birth name: Binyamin Netanyahu Father: Benzion Netanyahu, a ...
This panel brings together experts from Wolf Greenfield, BlueRock Therapeutics, BioNTech, and Generate Biomedicines to ...
A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that ...
U.S. Rep. Nancy Mace has reintroduced Thursday the VA Flood Preparedness Act, a bill aimed at safeguarding Veterans Affairs ...
The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell ...
With the global rights to imdusiran back in its hands, Arbutus is poised to further its development. Additionally, Arbutus ...
Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company focused on infectious disease, announced that it has reacquired China rights to its lead compound, imdusiran, from Qilu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results